1. Cardio, Inc., makes and sells Drawdown, the most prescribed name–
brand heart medication. Emitate Corporation has the potential to make
a generic version of the same drug. Cardio pays Emitate not to sell its
product. This is most likely
a. a deal that neither restrains trade or harms competition.
b. a legal restraint of trade.
c. a per se violation of the Sherman Act.
d. subject to analysis under the rule of reason.
1. Engine Components, Inc., a manufacturer of vehicle parts, refuses to
sell to Fix-It, Inc., a national vehicle service firm. Engine Components
convinces Greasy Motor Parts Company, a competitor, to do the same.
This is
a. a group boycott.
b. an exclusive-dealing contract.
c. a price-fixing agreement.
d. a tying arrangement.